News

News

PublISHED ON

UpDATED ON

Research funding available for next-generation biologics

The Swedish Research Council and Vinnova have formulated a national programme for protein research, method development and production of biologics. It is now possible to apply for up to 10 million SEK for protein research and process development for biologics. The call closes January 15, 2019. 

The programme is a part of the government’s strategic investment in life science aiming to promote better health, face societal challenges, strengthen Sweden’s position as a leading country for research and development, and increase Sweden’s competitiveness in an international perspective.

The programme contains both protein research for biologics, as well as development of more efficient methods for next-generation production of biologics. The programme runs from 2016 to 2023 and comprises 320 million SEK in total.

A call for protein research and process development for biologics is now open and closes January 15, 2019.

You can find all the information (in Swedish) about the call on Vinnova’s website External link..

PUBLISHED ON

UpDATED ON

Pdf / Printout


MORE WITHIN THE SAME SUBJECT AREA

  1. Inauguration of the new centre of excellence Chemical Mechanisms of Life

    On 12 of April, there will be an inauguration of one of the new centres of excellence with funding from the Swedish Research Council: Chemical Mechanisms of Life – an interdisciplinary centre for research into the chemistry of life. Mattias Marklund,...

  2. The Swedish Research Council’s centres of excellence

    The Swedish Research Council is funding 15 centres of excellence as from 2024. The centres, which are being built up, shall carry out ground-breaking research and educational activities around a central theme.

  3. Just over 75 per cent of clinical studies registered after one year

    As from 2022, all clinical studies funded by the Swedish Research Council shall be registered in a public database. A recent follow-up shows that the majority of the clinical studies awarded funding in 2022 have been registered.